Skip to content
Search

Latest Stories

Cigarette maker Philip Morris clinches £1bn takeover of inhaler maker Vectura; RPS, health organisations 'deeply concerned'

US cigarette firm Philip Morris International (PMI) on Thursday clinched a controversial takeover of British breathing inhaler manufacturer Vectura, despite fierce opposition from health campaigners and medical groups.

The Marlboro-maker agreed in July to pay £1.0 billion as part of a broader push into healthcare.


PMI on Thursday (September 16) said it had since won the necessary support from investors and secured regulatory approvals.

The acquisition is part of PMI's plans to expand beyond tobacco and nicotine and into a broader healthcare company.

"We have reached an important milestone in our acquisition of Vectura," PMI chief executive Jacek Olczak said in a statement.

The group has identified respiratory drug delivery as a key focus, under broader plans to generate at least $1.0 billion in annual net revenues from nicotine-free products by 2025.

"We are very excited about the critical role Vectura will play in our Beyond Nicotine strategy and look forward to working with Vectura's scientists and providing them with the resources and expertise to grow their business to help us achieve our goal," added Olczak.

Since 2008, the cigarette giant has invested more than $8.0 billion in smoke-free products, such as vaping, which it says is less harmful than smoking.

However, the Vectura takeover has faced heavy criticism from charities and medical groups.

The healthcare community believes that the announced takeover will legitimise tobacco industry participation within health debates and provide a greater platform from which to deploy similar tactics in support of tobacco industry interests.

Fierce opposition

More than 20 organisations, including anti-smoking charities and public health groups, together wrote to Vectura management urging it to reconsider the takeover on ethical and practical grounds.

Health organisations and charities have also written to pharmacy minister Jo Churchill to express deep concerns about the takeover of Vectura.

Sarah Woolnough, chief executive of both Asthma UK and the British Lung Foundation, accused Vectura of seeking a quick profit.

"Vectura has sold out millions of people with lung disease, and instead prioritised short-term financial gain over the long-term viability of Vectura as a business," she said.

"Vectura is now owned by a tobacco company, and this could cause considerable problems, such as the firm being excluded from research and clinical networks."

She added that it "creates perverse incentives for Philip Morris International to sell more of its harmful products so they might then profit again through treating smoking-related diseases".

RPS deeply concerned 

President of Royal Pharmaceutical Society Claire Anderson, who is a signatory of the letter to Churchill, said: “We are deeply concerned about today’s takeover of Vectura by Philip Morris International.

“This takeover not only creates an ethical dilemma for healthcare professionals but poses a threat of the tobacco industry participating in health debates and benefitting from this involvement.

“Therefore, we have signed the letter urging the Government to enforce FCTC Article 5.3, and to make any guidance given to departments dealing with Vectura public.”

More For You

GPhC should consider reduced fees for pharmacists non-practising practising, says RPS

RPS responds to GPhC consultation on draft changes to fees

gettyimages

RPS urges GPhC to reduce registration fees for non-practising pharmacists

The Royal Pharmaceutical Society (RPS) has called on the General Pharmaceutical Council (GPhC) to reduce annual registration fees for non-practising pharmacists — such as those on parental leave or with a long-term illness — in response to the regulator’s consultation on proposed changes to fees.

The GPhC is proposing a 6% increase in annual registration fees from September 2025 to cover the rising operational costs.

Keep ReadingShow less
Nick Kaye
Nick Kaye appointed as NPA's new chair
Nick Kaye appointed as NPA's new chair

Breaking news: NPA members advised against collective action

With the government’s recent announcement of increased funding to the sector signalling a ‘clear step forward’, the National Pharmacy Association (NPA) has today announced that it will not be recommending collective action to its members.

Last month, the department of health announced the Community Pharmacy Contractual Framework (CPCF) with an increase in funding for 2024/25 of £106m to £2.7 billion and simultaneously a further increase to £3.1 billion for 25/26.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less